Safety Study of Recombinant NAPc2 to Prevent Tumor Progression and Metastases in Metastatic Colon Cancer
Clinical trial NCT00443573 · SUSPENDED
Trial details
- NCT number
- NCT00443573
- Sponsor
- ARCA Biopharma, Inc.
- Status
- SUSPENDED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2007-08-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.